Development
CME Group Inc.
CME
$271.08
$1.380.51%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 10.49% | 6.89% | 7.71% | 7.79% | 9.48% |
| Total Other Revenue | 24.18% | 147.02% | 119.83% | 55.23% | 14.85% |
| Total Revenue | 11.19% | 10.45% | 10.87% | 9.59% | 9.74% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 11.19% | 10.45% | 10.87% | 9.59% | 9.74% |
| SG&A Expenses | 7.81% | 6.45% | 5.46% | 2.91% | -1.74% |
| Depreciation & Amortization | -2.76% | -2.62% | -3.78% | -5.20% | -5.92% |
| Other Operating Expenses | 0.53% | 8.62% | 0.10% | -4.65% | -9.70% |
| Total Operating Expenses | 5.22% | 5.01% | 3.21% | 0.63% | -3.31% |
| Operating Income | 15.17% | 14.31% | 16.60% | 16.54% | 20.62% |
| Income Before Tax | 19.00% | 14.81% | 5.50% | 5.46% | 3.46% |
| Income Tax Expenses | 16.03% | 18.04% | 19.72% | 13.42% | 8.50% |
| Earnings from Continuing Operations | 19.89% | 13.86% | 1.84% | 3.27% | 2.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.89% | 13.86% | 1.84% | 3.27% | 2.07% |
| EBIT | 15.17% | 14.31% | 16.60% | 16.54% | 20.62% |
| EBITDA | 13.24% | 12.37% | 14.12% | 13.80% | 17.06% |
| EPS Basic | 19.78% | 14.27% | 1.74% | 2.93% | 1.43% |
| Normalized Basic EPS | 18.90% | 21.84% | 23.78% | 24.61% | 23.35% |
| EPS Diluted | 19.92% | 14.39% | 1.93% | 3.09% | 1.45% |
| Normalized Diluted EPS | 18.91% | 21.87% | 23.82% | 24.65% | 23.38% |
| Average Basic Shares Outstanding | 0.09% | 0.09% | 0.09% | 0.09% | 0.10% |
| Average Diluted Shares Outstanding | 0.08% | 0.06% | 0.06% | 0.06% | 0.08% |
| Dividend Per Share | 10.00% | 10.26% | 10.53% | 10.81% | 11.11% |
| Payout Ratio | 0.02% | 0.24% | 0.39% | 0.38% | 0.39% |